WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life
NEW DELHI: The WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said. The WHO has also sought a meeting with Drugs Controller General of India (DCGI) to discuss the matter, they said. The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.
Read more atÂ
The New Indian Express
Timeline
.......... .......... .......... .......... ..........
- .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
- .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
- .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
- .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
Get the full picture.
For the full story from 1 other publisher, get Crisp on your smartphone.
In-depth coverage
Read more top National stories on Crisp